TMEM97 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.872400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.855600E-01
Normal-vs-Stage2
5.479400E-01
Normal-vs-Stage3
9.412200E-01
Normal-vs-Stage4
5.904600E-01
Stage1-vs-Stage2
7.326600E-01
Stage1-vs-Stage3
5.993600E-01
Stage1-vs-Stage4
9.263600E-01
Stage2-vs-Stage3
7.359800E-01
Stage2-vs-Stage4
6.944600E-01
Stage3-vs-Stage4
6.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.321800E-01
Normal-vs-AfricanAmerican
7.508800E-01
Normal-vs-Asian
2.873200E-01
Caucasian-vs-AfricanAmerican
7.734800E-01
Caucasian-vs-Asian
3.131400E-01
AfricanAmerican-vs-Asian
2.699200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.180400E-01
Normal-vs-Female
5.885600E-01
Male-vs-Female
4.992200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.973400E-01
Normal-vs-Age(41-60Yrs)
2.413800E-01
Normal-vs-Age(61-80Yrs)
6.708000E-01
Normal-vs-Age(81-100Yrs)
4.148400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.800000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.257800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.598200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.832000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.624400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.360800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.769000E-01
Normal-vs-Daily Drinker
2.688600E-01
Normal-vs-Weekly Drinker
5.883800E-01
Normal-vs-Occasional Drinker
5.431200E-01
Normal-vs-Social Drinker
4.632400E-01
Non Drinker-vs-Daily Drinker
2.940000E-02
Non Drinker-vs-Weekly Drinker
2.821200E-01
Non Drinker-vs-Occasional Drinker
2.042400E-02
Non Drinker-vs-Social Drinker
1.597040E-01
Daily Drinker-vs-Weekly Drinker
4.720600E-01
Daily Drinker-vs-Occasional Drinker
8.530600E-01
Daily Drinker-vs-Social Drinker
6.917200E-01
Weekly Drinker-vs-Occasional Drinker
3.956600E-01
Weekly Drinker-vs-Social Drinker
7.761800E-01
Occasional Drinker-vs-Social Drinker
5.865400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.256400E-01
Normal-vs-Grade 2
5.914800E-01
Normal-vs-Grade 3
7.518000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.655200E-01
Grade 1-vs-Grade 3
6.896600E-01
Grade 1-vs-Grade 4
9.256400E-01
Grade 2-vs-Grade 3
4.064800E-01
Grade 2-vs-Grade 4
5.914800E-01
Grade 3-vs-Grade 4
7.518000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.469400E-01
Normal-vs-NonDiabetic
4.579000E-01
Diabetic-vs-NonDiabetic
6.071400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.725200E-01
Normal-vs-NoPancreatitis
5.534600E-01
Pancreatitis-vs-NoPancreatitis
2.708400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.421200E-01
Normal-vs-N1
6.488800E-01
N0-vs-N1
3.634400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.704000E-01
Normal-vs-TP53-NonMutant
9.072000E-01
TP53-Mutant-vs-TP53-NonMutant
9.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
